The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relationship of minimal residual disease (MRD) in acute lymphocytic leukemia (ALL) and putative leukemia stem cells (LSCs).
 
Jonathan Michael Gerber
Research Funding - Janssen Research & Development (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No. 9,012,215; U.S. Track One Patent Application No. 15/796,201
 
Elizabeth Jandrisevits
No Relationships to Disclose
 
Lawrence Druhan
No Relationships to Disclose
 
Amanda Lance
No Relationships to Disclose
 
Andrea Price
No Relationships to Disclose
 
Virginia Thurston
No Relationships to Disclose
 
Jing Ai
No Relationships to Disclose
 
Thomas Gregory Knight
No Relationships to Disclose
 
Brittany K. Ragon
No Relationships to Disclose
 
Mitchell Turner
No Relationships to Disclose
 
Edward H. Lipford
No Relationships to Disclose
 
Edward Alan Copelan
Consulting or Advisory Role - Juno Therapeutics (I)
 
Michael Richard Grunwald
Stock and Other Ownership Interests - Medtronic
Honoraria - Imedex; TotalCME
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; ARIAD; Cardinal Health; Celgene; Incyte; Pfizer
Research Funding - Amgen (Inst); FORMA Therapeutics (Inst); Genentech/Roche (Inst); Incyte (Inst); Janssen (Inst)
 
Belinda Rene Avalos
Consulting or Advisory Role - Juno Therapeutics
 
David Foureau
No Relationships to Disclose